Press release
Histone Deacetylase Inhibitors Market to Reach USD 2.14 Bn by 2030
๐๐ข๐ฌ๐ญ๐จ๐ง๐ ๐๐๐๐๐๐ญ๐ฒ๐ฅ๐๐ฌ๐ ๐๐ง๐ก๐ข๐๐ข๐ญ๐จ๐ซ๐ฌ ๐๐๐ซ๐ค๐๐ญ ๐๐ซ๐จ๐ฐ๐ญ๐ก ๐จ๐ซ ๐๐๐ฆ๐๐ง๐ ๐๐ง๐๐ซ๐๐๐ฌ๐ ๐จ๐ซ ๐๐๐๐ซ๐๐๐ฌ๐ ๐๐จ๐ซ ๐ฐ๐ก๐๐ญ ๐๐จ๐ง๐ญ๐๐ข๐ง๐ฌ :The Histone Deacetylase Inhibitors Market is experiencing a steady increase in demand. This growth is driven by the rising prevalence of chronic diseases such as cancer and neurodegenerative disorders, where these inhibitors play a crucial role in treatment. Histone deacetylase inhibitors, which target enzymes involved in gene expression regulation, are gaining attention for their potential in modifying disease outcomes and enhancing therapeutic efficacy. With ongoing research and development, the market is expected to see continued expansion as new treatments are explored and clinical applications broaden.
๐๐ข๐ฌ๐ญ๐จ๐ง๐ ๐๐๐๐๐๐ญ๐ฒ๐ฅ๐๐ฌ๐ ๐๐ง๐ก๐ข๐๐ข๐ญ๐จ๐ซ๐ฌ ๐๐๐ซ๐ค๐๐ญ ๐๐๐๐ ๐๐ฌ๐ญ๐ข๐ฆ๐๐ญ๐ข๐จ๐ง:
The size of the global market for histone deacetylase inhibitors was estimated at USD 1.27 billion in 2023, and it is anticipated that sales of these products will increase by 7.74% between 2024 and 2030 to reach around USD 2.14 billion.
๐๐ฑ๐ฉ๐ฅ๐จ๐ซ๐ ๐๐๐๐ข๐ญ๐ข๐จ๐ง๐๐ฅ ๐๐๐ญ๐๐ข๐ฅ๐ฌ ๐๐ฒ ๐๐ฅ๐ข๐๐ค๐ข๐ง๐ ๐ญ๐ก๐ ๐ฅ๐ข๐ง๐ค ๐ฉ๐ซ๐จ๐ฏ๐ข๐๐๐:https://www.maximizemarketresearch.com/request-sample/30506/
๐๐ข๐ฌ๐ญ๐จ๐ง๐ ๐๐๐๐๐๐ญ๐ฒ๐ฅ๐๐ฌ๐ ๐๐ง๐ก๐ข๐๐ข๐ญ๐จ๐ซ๐ฌ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ ๐ฆ๐๐ง๐ญ๐๐ญ๐ข๐จ๐ง:
๐๐ฒ ๐๐ฅ๐๐ฌ๐ฌ
Class I HDACs
Class II HDACs
Class III HDACs
Class IV HDACs
Class I HDAC dominated the market for histone deacetylase inhibitors based on class because it is frequently linked to a number of tumors and is therefore a popular target in cancer treatment. Inhibitors that target Class I HDACs, including entinostat and panobinostat, have demonstrated potential in the treatment of breast cancer and multiple myeloma. Because class II HDACs are linked to both cancer and neurological diseases, the market for histone deacetylase inhibitors is expanding quickly. Research is currently being conducted to investigate the therapeutic potential of class III HDACs, commonly referred to as sirtuins, which have gained attention because to their possible involvement in age-related disorders. Although class IV HDACs are less well-defined, more research is necessary since they may have consequences for cancer and other disorders.
๐๐ฒ ๐๐ฉ๐ฉ๐ฅ๐ข๐๐๐ญ๐ข๐จ๐ง
Oncology
Neurology
Others
Application-wise, the oncology sector led the market due to the significant increase of HDAC inhibitors and the rising number of cancer cases. They are used in multiple myeloma, breast cancer, cutaneous T-cell lymphoma, and other cancers where they play a critical role in epigenetic control. Notable HDAC inhibitors for cancer therapies include romidepsin from Celgene and panobinostat from Novartis. HDAC inhibitors have drawn interest in the field of neurology due to their possible treatment of neurodegenerative conditions including multiple sclerosis.
๐๐ฒ ๐๐ง๐ ๐๐ฌ๐๐ซ
Hospitals
Oncology Clinics
Others
๐๐ข๐ฌ๐ญ๐จ๐ง๐ ๐๐๐๐๐๐ญ๐ฒ๐ฅ๐๐ฌ๐ ๐๐ง๐ก๐ข๐๐ข๐ญ๐จ๐ซ๐ฌ ๐๐๐ซ๐ค๐๐ญ ๐๐ฏ๐๐ซ๐ฏ๐ข๐๐ฐ
The Histone Deacetylase (HDAC) Inhibitors Market is witnessing significant growth due to their critical role in cancer therapy and the treatment of various neurological and inflammatory diseases. HDAC inhibitors work by modifying histones and other proteins, which impacts gene expression and can lead to therapeutic benefits in conditions where gene regulation is disrupted. The market is expanding as new HDAC inhibitors are developed and approved, reflecting their increasing use in clinical settings. Research into their applications continues to advance, promising further market growth as these therapies are integrated into treatment regimens for a broader range of diseases
๐๐ฑ๐ฉ๐ฅ๐จ๐ซ๐ ๐๐๐๐ข๐ญ๐ข๐จ๐ง๐๐ฅ ๐๐๐ญ๐๐ข๐ฅ๐ฌ ๐๐ฒ ๐๐ฅ๐ข๐๐ค๐ข๐ง๐ ๐ญ๐ก๐ ๐ฅ๐ข๐ง๐ค ๐ฉ๐ซ๐จ๐ฏ๐ข๐๐๐:https://www.maximizemarketresearch.com/request-sample/30506/
๐๐ข๐ฌ๐ญ๐จ๐ง๐ ๐๐๐๐๐๐ญ๐ฒ๐ฅ๐๐ฌ๐ ๐๐ง๐ก๐ข๐๐ข๐ญ๐จ๐ซ๐ฌ ๐๐๐ซ๐ค๐๐ญ ๐๐ซ๐จ๐ฐ๐ญ๐ก ๐จ๐ซ ๐๐๐ฆ๐๐ง๐ ๐ข๐ง ๐ฐ๐ก๐ข๐๐ก ๐ซ๐๐ ๐ข๐จ๐ง๐ฌ??
The research includes in-depth examinations of the Middle East, South America, Europe, Africa, and Asia-Pacific region. Understanding the intricate dynamics of the Histone Deacetylase Inhibitors Market is one aspect of regional analysis. A framework of product imports and exports by nations and regions, as well as market sizes and growth rates for Histone Deacetylase Inhibitors , are included in the report. An overview of the most current developments in the field from a number of different countries and areas is given in this paper.
๐๐ข๐ฌ๐ญ๐จ๐ง๐ ๐๐๐๐๐๐ญ๐ฒ๐ฅ๐๐ฌ๐ ๐๐ง๐ก๐ข๐๐ข๐ญ๐จ๐ซ๐ฌ ๐๐๐ซ๐ค๐๐ญ ๐๐๐จ๐ฉ๐ ๐๐ง๐ ๐๐๐ญ๐ก๐จ๐๐จ๐ฅ๐จ๐ ๐ฒ:
The approach that gives investors relevant information by combining SWOT and descriptive analysis is covered in the report. The study's main objective is to provide a comprehensive picture of the Histone Deacetylase Inhibitors Market . The process of gathering data uses a variety of methods, such as surveys and questionnaires. Following this, mathematical, statistical, and numerical approaches are used to evaluate the data. It takes a combination of qualitative and quantitative research approaches to identify Histone Deacetylase Inhibitors Market trends, so gathering and processing data is crucial.By carefully examining the situation of buyer-direct, RD initiatives, innovative forms of development, cutting-edge industry techniques, and market consolidations and acquisitions, the research evaluates the potential futures of the market. The research includes methods, organizational charts, portfolios, and a critical evaluation of well-known corporate executives. Histone Deacetylase Inhibitors Doors underwent a thorough PESTLE study and SWOT analysis in order to provide microeconomic variables and detect market trends.
๐ ๐จ๐ซ ๐ ๐๐๐๐ฉ๐๐ซ ๐ฎ๐ง๐๐๐ซ๐ฌ๐ญ๐๐ง๐๐ข๐ง๐ , ๐๐ฅ๐ข๐๐ค ๐จ๐ง ๐ญ๐ก๐ ๐ฅ๐ข๐ง๐ค:https://www.maximizemarketresearch.com/request-sample/30506/
๐๐ข๐ฌ๐ญ๐จ๐ง๐ ๐๐๐๐๐๐ญ๐ฒ๐ฅ๐๐ฌ๐ ๐๐ง๐ก๐ข๐๐ข๐ญ๐จ๐ซ๐ฌ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฒ ๐๐ฅ๐๐ฒ๐๐ซ๐ฌ
1. 4SC AG -: Planegg-Martinsried, Germany
2. Beactica AB -: Uppsala, Sweden
3. Beigene Ltd. -: Beijing, China
4. Biotheryx, Inc. -: San Diego, California, USA
5. CanBas Co., Ltd. -: Kobe, Japan
6. Celgene Corporation (Now part of Bristol-Myers Squibb) -: Summit, New Jersey, USA
7. Cellerant Therapeutics, Inc. -: San Carlos, California, USA
8. Celleron Therapeutics Ltd. -: London, United Kingdom
9. Eisai Co., Ltd. -: Tokyo, Japan
10. EnVivo Pharmaceuticals, Inc. -: Watertown, Massachusetts, USA
11. Forma Therapeutics Holdings, LLC -: Watertown, Massachusetts, USA
12. HUYA Bioscience International -: San Diego, California, USA
13. Merck & Co., Inc. -: Kenilworth, New Jersey, USA
14. Mirati Therapeutics, Inc. -: San Diego, California, USA
15. Mirum Pharmaceuticals, Inc. -: Foster City, California, USA
16. Novartis International AG -: Basel, Switzerland
17. Oncoceutics, Inc. -: Philadelphia, Pennsylvania, USA
18. Pfizer Inc. -: New York City, New York, USA
19. Pharmacyclics LLC (A subsidiary of AbbVie Inc.) -: Sunnyvale, California, USA
20. Shenzhen Chipscreen Biosciences Co., Ltd. -: Shenzhen, China
๐๐จ ๐๐๐๐๐ฌ๐ฌ ๐ฆ๐จ๐ซ๐ ๐๐จ๐ฆ๐ฉ๐ซ๐๐ก๐๐ง๐ฌ๐ข๐ฏ๐ ๐ข๐ง๐๐จ๐ซ๐ฆ๐๐ญ๐ข๐จ๐ง, ๐๐ฅ๐ข๐๐ค ๐ก๐๐ซ๐: @https://www.maximizemarketresearch.com/market-report/global-histone-deacetylase-inhibitors-market/30506/
๐๐๐ฒ ๐ช๐ฎ๐๐ฌ๐ญ๐ข๐จ๐ง๐ฌ ๐๐ง๐ฌ๐ฐ๐๐ซ๐๐ ๐ข๐ง ๐ญ๐ก๐ ๐๐ข๐ฌ๐ญ๐จ๐ง๐ ๐๐๐๐๐๐ญ๐ฒ๐ฅ๐๐ฌ๐ ๐๐ง๐ก๐ข๐๐ข๐ญ๐จ๐ซ๐ฌ ๐๐๐ซ๐ค๐๐ญ ๐๐ซ๐:
โข What is Histone Deacetylase Inhibitors ?
โข What is the growth rate of the Histone Deacetylase Inhibitors ?
โข Which are the factors expected to drive the Histone Deacetylase Inhibitors market growth?
โข What are the different segments of the Histone Deacetylase Inhibitors ?
โข What growth strategies are the players considering to increase their presence in Histone Deacetylase Inhibitors ?
โข What are the upcoming industry applications and trends for the Histone Deacetylase Inhibitors ?
โข What are the recent industry trends that can be implemented to generate additional revenue streams for the Histone Deacetylase Inhibitors ?
โข What major challenges could the Histone Deacetylase Inhibitors face in the future?
โข What segments are covered in the Histone Deacetylase Inhibitors ?
โข Who are the leading companies and what are their portfolios in Histone Deacetylase Inhibitors ?
โข What segments are covered in the Histone Deacetylase Inhibitors ?
โข Who are the key players in the Histone Deacetylase Inhibitors market?
๐๐๐ฅ๐๐ญ๐๐ ๐๐๐ฉ๐จ๐ซ๐ญ๐ฌ:
โฆ Kinetic Tiles Market https://www.maximizemarketresearch.com/market-report/kinetic-tiles-market/184256/
โฆ Data Visualization Software Market https://www.maximizemarketresearch.com/market-report/global-data-visualization-software-market/79395/
โฆ Online Event Ticketing Market https://www.maximizemarketresearch.com/market-report/global-online-event-ticketing-market/23536/
โฆ Industrial Evaporators Market https://www.maximizemarketresearch.com/market-report/industrial-evaporators-market/187468/
โฆ Oil Spill Management Market https://www.maximizemarketresearch.com/market-report/oil-spill-management-market/187500/
โฆ Single Use Filtration Assembly Market https://www.maximizemarketresearch.com/market-report/single-use-filtration-assembly-market/187509/
โฆ Suture Needles Market https://www.maximizemarketresearch.com/market-report/suture-needles-market/189824/
โฆ Amino Acids Market https://www.maximizemarketresearch.com/market-report/amino-acids-market/190304/
โฆ Sports Tourism Market https://www.maximizemarketresearch.com/market-report/sports-tourism-market/191030/
โฆ Cured-In-Place Pipe Consumption Market https://www.maximizemarketresearch.com/market-report/cured-in-place-pipe-consumption-market/194745/
๐๐จ๐ง๐ญ๐๐๐ญ ๐๐๐ฑ๐ข๐ฆ๐ข๐ณ๐ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฌ๐๐๐ซ๐๐ก:
3rd Floor, Navale IT Park, Phase 2
Pune Banglore Highway, Narhe,
Pune, Maharashtra 411041, India
sales@maximizemarketresearch.com
+91 96071 95908, +91 9607365656
๐๐๐จ๐ฎ๐ญ ๐๐๐ฑ๐ข๐ฆ๐ข๐ณ๐ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฌ๐๐๐ซ๐๐ก:
Maximize Market Research is a multifaceted market research and consulting company with professionals from several industries. Some of the industries we cover include medical devices, pharmaceutical manufacturers, science and engineering, electronic components, industrial equipment, technology and communication, cars and automobiles, chemical products and substances, general merchandise, beverages, personal care, and automated systems. To mention a few, we provide market-verified industry estimations, technical trend analysis, crucial market research, strategic advice, competition analysis, production and demand analysis, and client impact studies.
This release was published on openPR.
Permanent link to this press release:
                     Copy
                  
                 Please set a link in the press area of your homepage to this press release on openPR.  openPR disclaims liability for any content contained in this release. 
    You can edit or delete your press release Histone Deacetylase Inhibitors Market to Reach USD 2.14 Bn by 2030 here
News-ID: 3631017 • Views: โฆ
More Releases from MAXIMIZE MARKET RESEARCH PVT. LTD.
 
                                            
                                                    Clinical Trials Market Set to Reach USD 88.26 Billion by 2032 with a 6.13% CAGR  โฆ                                                
                                            
                                        
                                            According to a new report by Maximize Market Research, the global Clinical Trials Market was valued at USD 54.83 billion in 2024 and is projected to reach USD 88.26 billion by 2032, growing at a CAGR of 6.13%. A major surge in biopharmaceutical R&D and oncology-focused studies is driving the global clinical trials market toward nearly USD 88.26 billion by 2032 at a 6.13% CAGR.
โบ Get a sample of theโฆ  
                                        
                                     
                                            
                                                    Turbo Trainer Market to Reach USD 421.03 Million by 2032, Growing at a CAGR of 5 โฆ                                                
                                            
                                        
                                            Turbo Trainer Market size was valued at USD 281.52 Mn. in 2024 and the total Turbo Trainer revenue is expected to grow at 5.16% through 2025 to 2032, reaching nearly USD 421.03 Mn.
Turbo Trainer Market Overview:
The Turbo Trainer Market is witnessing significant growth as fitness enthusiasts increasingly adopt indoor cycling equipment for year-round training. Turbo trainers, which allow users to convert regular bicycles into stationary exercise machines, have become essentialโฆ  
                                        
                                     
                                            
                                                    Sodium Acetate Market to Reach USD 354.24 Million by 2032, Growing at a CAGR of  โฆ                                                
                                            
                                        
                                            Sodium Acetate Market size was valued at USD 206.17 Million in 2024, and the total revenue is expected to grow at CAGR of 7 % from 2025 to 2032, reaching nearly USD 354.24 Million.
Sodium Acetate Market Overview:
The Sodium Acetate Market is experiencing steady growth due to its widespread applications across industries such as food and beverage, pharmaceuticals, textiles, and chemical manufacturing. Sodium acetate, a versatile salt of acetic acid, isโฆ  
                                        
                                     
                                            
                                                    India Tire Market to Reach USD 27.6 Billion by 2033 at 7.6 % CAGR - "India Tire  โฆ                                                
                                            
                                        
                                            According to a new report by Maximize Market Research, the India tire market was valued at approximately USD 13.4 billion in 2024 and is expected to climb to USD 27.6 billion by 2033, representing a compound annual growth rate (CAGR) of about 7.6 %. The growth is underpinned by increasing automotive production, growing replacement demand, and rising adoption of radial tyres.
โบ Get a sample of the report:https://www.maximizemarketresearch.com/request-sample/21022/
โฆ Key Highlights
Market sizeโฆ  
                                        
                                    More Releases for Histone
                                                    Histone Deacetylase (HDAC) Inhibitors Market 2022 | Detailed Report                                                
                                            
                                        
                                            The Histone Deacetylase (HDAC) Inhibitors research report undoubtedly meets the strategic and specific needs of the businesses and companies. The report acts as a perfect window that provides an explanation of market classification, market definition, applications, market trends, and engagement. The competitive landscape is studied here in terms of product range, strategies, and prospects of the market's key players. Furthermore, the report offers insightful market data and information about theโฆ  
                                        
                                    
                                                    Histone Deacetylase 8 (Histone Deacetylase Like 1 or HDAC8 or EC 3.5.1.98) Marke โฆ                                                
                                            
                                        
                                            The Histone Deacetylase 8 (Histone Deacetylase Like 1 or HDAC8 or EC 3.5.1.98) Market report offers an in-depth assessment of market dynamics, the competitive landscape, segments, and regions in order to help readers to become familiar with the Histone Deacetylase 8 (Histone Deacetylase Like 1 or HDAC8 or EC 3.5.1.98) market. It particularly sheds light on market fluctuations, pricing structure, uncertainties, potential risks, and growth prospects to help players toโฆ  
                                        
                                    
                                                    Global Histone Deacetylase Inhibitors Market Research Report                                                
                                            
                                        
                                            This report studies the global Histone Deacetylase Inhibitors market status and forecast, categorizes the global Histone Deacetylase Inhibitors market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report 4SC AG Acetylon Pharmaceuticals Celleron Therapeutics Chroma Therapeutics CrystalGenomics Curis MEI Pharma Mirati Therapeutics Novartisโฆ  
                                        
                                    
                                                    Histone Deacetylase Inhibitors Market & Pipeline Insight2015                                                
                                            
                                        
                                            Histone Deacetylase (HDAC) are enzymes responsible for removal of acetyl groups present on acetyl lysine amino acid attached to histone. They are responsible for gene expression and regulation which is responsible for cellular functioning. It also helps in wrapping of histone over the Deoxyribonucleic acid (DNA). They are involved in cell growth and death which is responsible for maintaining steady state. Their involvement in diseases has been noted by investigatorsโฆ  
                                        
                                    
                                                    Histone Deacetylase 4 (Histone Deacetylase A or HDAC4 or EC 3.5.1.98) - Pipeline โฆ                                                
                                            
                                        
                                            The latest report Histone Deacetylase 4 - Pipeline Review, H1 2017, outlays comprehensive information on the Histone Deacetylase 4 (Histone Deacetylase A or HDAC4 or EC 3.5.1.98) targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviewsalso reviews key players involved in Histone Deacetylase 4 (Histone Deacetylase A or HDAC4 or EC 3.5.1.98) targeted therapeutics developmentโฆ  
                                        
                                    
                                                    Global Histone Deacetylase Inhibitors Market                                                
                                            
                                        
                                            Histone deacetylase (HDAC) is enzymes, which inhibits histone deacetylase by removing scetyl group from n-acetyl lysine amino acid. Histone deacetylase inhibitors are emerging as potential application in diagnosis, treatment and prognosis of cancer. It is also considered as a treatment option for hematological malignancies and plays important role in epigenetic or non-epigenetic regulation. The histone deacetylase inhibitors accumulates acetylated nuclear histone in tumors and normal tissues. Thus, the inhabitation resultsโฆ  
                                        
                                    